Mycobacterium branderi

Revision as of 18:09, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Mycobacterium branderi
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. branderi
Binomial name
Mycobacterium branderi
Koukila-Kähkölä et al. 1995, ATCC 51304

WikiDoc Resources for Mycobacterium branderi

Articles

Most recent articles on Mycobacterium branderi

Most cited articles on Mycobacterium branderi

Review articles on Mycobacterium branderi

Articles on Mycobacterium branderi in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mycobacterium branderi

Images of Mycobacterium branderi

Photos of Mycobacterium branderi

Podcasts & MP3s on Mycobacterium branderi

Videos on Mycobacterium branderi

Evidence Based Medicine

Cochrane Collaboration on Mycobacterium branderi

Bandolier on Mycobacterium branderi

TRIP on Mycobacterium branderi

Clinical Trials

Ongoing Trials on Mycobacterium branderi at Clinical Trials.gov

Trial results on Mycobacterium branderi

Clinical Trials on Mycobacterium branderi at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mycobacterium branderi

NICE Guidance on Mycobacterium branderi

NHS PRODIGY Guidance

FDA on Mycobacterium branderi

CDC on Mycobacterium branderi

Books

Books on Mycobacterium branderi

News

Mycobacterium branderi in the news

Be alerted to news on Mycobacterium branderi

News trends on Mycobacterium branderi

Commentary

Blogs on Mycobacterium branderi

Definitions

Definitions of Mycobacterium branderi

Patient Resources / Community

Patient resources on Mycobacterium branderi

Discussion groups on Mycobacterium branderi

Patient Handouts on Mycobacterium branderi

Directions to Hospitals Treating Mycobacterium branderi

Risk calculators and risk factors for Mycobacterium branderi

Healthcare Provider Resources

Symptoms of Mycobacterium branderi

Causes & Risk Factors for Mycobacterium branderi

Diagnostic studies for Mycobacterium branderi

Treatment of Mycobacterium branderi

Continuing Medical Education (CME)

CME Programs on Mycobacterium branderi

International

Mycobacterium branderi en Espanol

Mycobacterium branderi en Francais

Business

Mycobacterium branderi in the Marketplace

Patents on Mycobacterium branderi

Experimental / Informatics

List of terms related to Mycobacterium branderi

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mycobacterium branderi is a slowly growing, nonchromogenic Mycobacterium first isolated from patients in Finland. Etymology: of Brander, referring to Eljas Brander, the former head of the Tuberculosis Laboratory of the National Public Health Institute, Finland, who collected the strains.


Description

Microscopy

  • Acid-fast delicate slender rods that are often slightly curved, 1.2 to 3 um long.

Colony characteristics

  • Colonies are nonchromogenic and produce smooth, often umbonate, off-white to grayish colonies on Middlebrook 7H11 agar.

Physiology

  • Slowly growing, reaching full colony size after 2 to 3 weeks.
  • Growth is equally good at 37C and 45C and is only slightly delayed at 25C.
  • The type strain is negative for Tween 80 hydrolysis, catalase, urease, and nitrate reductase activities and niacin.
  • Strongly positive for arylsulfatase activity in 14-day tests and moderately to weakly positive for nicotinamidase and pyrazinamidase activities.
  • In susceptibility tests the type strain was resistant to isoniazid, rifampin, pyrazinamide, and cycloserine but susceptible to ethambutol, streptomycin, ethionamide, and capreomycin.

Differential characteristics

  • Differentiation by 16S rRNA sequencing
  • Distinguishing of M. branderi from M. celatum by pigment production
  • Differentiation of M. branderi from M. xenopi on the basis of good growth of M. branderi at room temperature, the lack of pigment production by M. branderi
  • Differentiation of M. branderi and M. cookii: M. cookii is scotochromogenic and does not grow at 37°C.

Pathogenesis

  • The first strains of M. branderi were isolated from samples obtained from nine patients, some of whom had cavitary mycobacteriosis of the lungs that was resistant to available drugs. In most cases, repeat samples obtained from each patient were positive for acid-fast bacilli as determined by microscopy, and the only cultivable species was M. branderi. M. branderi has to be considered a potential human pathogen.

Type Strain

  • Strain 52157 = ATCC 51789 = CIP 104592 = DSM 44624 = JCM 12687.

References

  • KOUKILA-KÄHKÖLÄ P., 1995. Mycobacterium branderi sp. nov., a new potential human pathogen. Int. J. Syst. Bacteriol., 45, 549-553.


de:Mycobacterium branderi nl:Mycobacterium branderi

Template:SIB


Template:WikiDoc Sources